123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.

@article{Pena2006123ITU,
  title={123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.},
  author={Samara Figueiredo Albernaz Pena and Seth M. Arum and Molly K. Cross and Barbarajean Magnani and Elizabeth N Pearce and M Elizabeth Oates and Lewis E. Braverman},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2006},
  volume={91 2},
  pages={
          506-10
        }
}
CONTEXT Recombinant human TSH (rhTSH) is used to evaluate thyroid carcinoma patients and off-label for (131)I thyroid ablation and nontoxic goiter therapy. OBJECTIVE Our objective was to determine the optimal time for (131)I administration after rhTSH. PARTICIPANTS Twenty-five euthyroid nongoitrous volunteers participated in the study. DESIGN Baseline 24-h thyroid (123)I uptake (RAIU) was measured, and then 0.1 mg rhTSH was administered. (123)I was administered 24, 48, or 72 h after rhTSH… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Similar Papers

Loading similar papers…